Ordaōs is a human-enabled, machine-driven drug design company. Their flagship solution, mini-PRO™, is a bespoke class of mini-proteins that help pharma and biotechs deliver safer and more effective life-saving treatments in a fraction of the time of traditional discovery methods.
